Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 August 2021 | Story Michelle Nöthling

What does the best university community look like? And what would a better South Africa look like?

In the last couple of weeks, our conversations have been dominated by topics of violence that have spilled into our communities. We have shared our fears with each other and talked about the complexities that gave rise to this rage within our society. We also witnessed communities pulling together in the midst of the destruction, reminding us of our common humanity. 

If you had the opportunity to help build the best university you could imagine, would you step into that space? If you could help create a prospering South African society, would you act?

This is what the Division of Student Affairs is calling you to do. Join us as we embark on a journey of reimagining and ultimately co-creating the community we want. It starts with a conversation. A conversation where your voice is important and welcomed, and where we regard your presence as essential to realise our shared dreams.

We call you as a member of the UFS community—students and staff alike—to join our circle of conversation. We will make use of deeply engaging methods and break-out rooms to create a safe and brave space that encourages mutual sharing and deep listening. 

Add your vision and voice to the conversation to collectively imagine and build the best version of our university.

UFS Community Conversation
Date: Wednesday, 1 September
Time: 16:00 – 18:00
Platform: Zoom (in order to best support universal access and methodology)

Registration is required:

For reasonable accommodation requirements (e.g., closed captioning, or sign language interpreters), contact Michelle Nöthling at nothlingm@ufs.ac.za.

We also have information session leading up to our main conversation. During these sessions, we welcome your questions and together start to explore the concept of community in a collaborative environment.  

Information sessions
Monday, 23 August 2021, 15:00 – 16:00
Tuesday, 24 August 2021, 15:00 – 16:00
Wednesday, 25 August 2021, 15:00 – 16:00
Thursday, 26 August 2021, 15:00 – 16:00
Monday, 30 August 2021, 15:00 – 16:00
Tuesday, 31 August 2021, 15:00 – 16:00

Click here to access any of the information sessions. No registration is required for these sessions.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept